+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Eubiotics Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 198 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336414
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The eubiotics market is transforming animal nutrition as organizations manage compliance, sustainability, and operational innovation. Senior leaders face continuous change driven by complex regulations and new technologies that are shaping both the competitive landscape and supply chain practices.

Eubiotics Market Snapshot: Size and Growth Dynamics

The global eubiotics market is demonstrating sustained growth, projected to expand from USD 10.80 billion in 2024 to USD 12.55 billion in 2025, and forecasted to reach USD 36.54 billion by 2032. The market is advancing at a compound annual growth rate of 16.44%, supported by rising investment in cutting-edge feed additives, industry partnerships, and a sharper focus on animal health management. Technology integration and digitalization are streamlining feed supply chains, increasing operational resilience, and ensuring more effective animal nutrition strategies across key regions.

Eubiotics Market Scope & Segmentation

  • Product Types: Solutions include enzymes, organic acids, phytogenics, prebiotics, probiotics, and synbiotics, each optimizing feed efficiency and supporting animal well-being in diverse production environments.
  • Phytogenics: Herbal extracts, oleoresins, and spice derivatives help organizations align with region-specific regulations and advance environmental objectives.
  • Probiotics: Strains such as Bacillus, Enterococcus, Lactobacillus, and Saccharomyces promote digestive health and enhance animal performance across different rearing systems.
  • Livestock Types: Eubiotics are formulated for aquaculture, ruminant, swine, and poultry, enabling compliance and productivity across global operations.
  • Forms: Available formats—dry concentrates, liquid emulsions, premixes, and suspensions—address manufacturing requirements for both major producers and specialized operations.
  • Functions: Improving gut health, supporting feed utilization, optimizing growth, enabling immune support, and contributing to pathogen management within the animal nutrition value chain.
  • Sales Channels: Distribution spans traditional channels and digital procurement, giving industry stakeholders the flexibility to manage supply visibility and response times efficiently.
  • Geographies: Regional performance is driven by specific regulatory frameworks, demographic trends, and speed of technology adoption in the Americas, Europe, Middle East & Africa, and Asia-Pacific.
  • Industry Leaders: Major contributors such as Koninklijke DSM N.V., Evonik Industries AG, Novozymes A/S, Chr. Hansen Holding A/S, Cargill, Archer Daniels Midland Company, Kerry Group, BASF SE, DuPont de Nemours, and Ajinomoto are steering innovation and setting operational standards.

Eubiotics Market: Key Takeaways for Senior Leaders

  • New advances in fermentation and encapsulation processes are strengthening nutrient delivery and operational responsiveness within animal health initiatives.
  • Reductions in antibiotic use are reshaping production systems to better meet regulatory obligations and address customer requirements for sustainability and quality.
  • Growing digitalization is enhancing process oversight, supporting data-driven compliance, and strengthening risk management amid evolving regulations.
  • Partnerships among feed producers, biotech innovators, and research institutions are enabling rapid product development and market adaptation in competitive environments.
  • Automating procurement and inventory supports stronger supply chain continuity and helps organizations anticipate and mitigate critical sourcing risks.
  • Expanding local talent and knowledge is helping businesses remain agile and competitive during times of regulatory or market transition.

Tariff Impact: US Measures and Global Trade Realignment

Recent shifts in US tariff policies are prompting the eubiotics sector to reassess global trade frameworks and strategies for supply assurance. Businesses are prioritizing regionalized manufacturing and nearshoring, making vertical integration more essential to curb volatility. Enhanced partnerships with local suppliers and intra-regional networks are supporting regulatory compliance and stabilized business operations as trade patterns continue to change.

Methodology & Data Sources

This report synthesizes primary research from industry expert interviews, comprehensive secondary research, and robust quantitative analysis. All findings are validated by animal nutrition professionals to ensure they deliver credible guidance and practical utility for business stakeholders.

Why This Report Matters

  • Delivers a structured analysis of regulatory, technology, and regional factors that influence the eubiotics landscape for senior-level decision-making.
  • Equips executives with actionable strategies for compliance, innovation, and risk management as industry conditions shift.
  • Identifies targeted pathways for differentiation and sustainable growth in the evolving animal nutrition sector.

Conclusion

This report guides senior leaders as they adjust strategies and reinforce risk protocols, ensuring continued confidence and resilience in the changing animal nutrition and eubiotics markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Growing adoption of multi-strain probiotic blends to improve livestock gut microbiome and reduce antibiotic usage
5.2. Rising demand for natural phytogenic feed additives driven by consumer preference for antibiotic-free animal products
5.3. Innovation in microencapsulation technologies to enhance stability of eubiotic ingredients during feed processing
5.4. Strategic alliances between feed manufacturers and biotechnology firms accelerating eubiotic product development
5.5. Regulatory harmonization initiatives in EU and North America streamlining approval of novel gut health enhancers
5.6. Escalating investment in next-generation synbiotic formulations to optimize gut microbiota modulation in poultry production
5.7. Integration of digital biomarkers and precision feeding systems to monitor eubiotic impact on animal performance
5.8. Increasing focus on sustainability metrics driving adoption of plant-based prebiotics as antibiotic alternatives in feed
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Eubiotics Market, by Product Type
8.1. Enzymes
8.2. Organic Acids
8.3. Phytogenics
8.3.1. Herbs And Spices
8.3.2. Oleoresins
8.4. Prebiotics
8.5. Probiotics
8.5.1. Bacillus
8.5.2. Enterococcus
8.5.3. Lactobacillus
8.5.4. Saccharomyces
8.6. Synbiotics
9. Eubiotics Market, by Livestock Type
9.1. Aquaculture
9.1.1. Fish
9.1.2. Shrimp
9.2. Poultry
9.2.1. Broiler
9.2.2. Layer
9.2.3. Turkey
9.3. Ruminants
9.3.1. Beef
9.3.2. Dairy
9.4. Swine
9.4.1. Finisher
9.4.2. Sow
9.4.3. Weaner
10. Eubiotics Market, by Form
10.1. Dry
10.1.1. Concentrate
10.1.2. Premix
10.2. Liquid
10.2.1. Emulsion
10.2.2. Suspension
11. Eubiotics Market, by Function
11.1. Feed Efficiency
11.2. Growth Promoter
11.3. Gut Health
11.3.1. Intestinal Morphology
11.3.2. Pathogen Reduction
11.4. Immune Modulator
12. Eubiotics Market, by Sales Channel
12.1. Offline
12.2. Online
13. Eubiotics Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Eubiotics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Eubiotics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Koninklijke DSM N.V.
16.3.2. Evonik Industries AG
16.3.3. Novozymes A/S
16.3.4. Chr. Hansen Holding A/S
16.3.5. Cargill, Incorporated
16.3.6. Archer Daniels Midland Company
16.3.7. Kerry Group plc
16.3.8. BASF SE
16.3.9. DuPont de Nemours, Inc.
16.3.10. Ajinomoto Co., Inc.

Companies Mentioned

The companies profiled in this Eubiotics market report include:
  • Koninklijke DSM N.V.
  • Evonik Industries AG
  • Novozymes A/S
  • Chr. Hansen Holding A/S
  • Cargill, Incorporated
  • Archer Daniels Midland Company
  • Kerry Group plc
  • BASF SE
  • DuPont de Nemours, Inc.
  • Ajinomoto Co., Inc.

Table Information